Molecular adsorbent recirculating system as artificial support therapy for liver failure: a meta-analysis

Area of Science:

• Hepatology
• Artificial Organ Support
• Critical Care Medicine

Background:

• Liver failure necessitates advanced support systems.
• The Molecular Adsorbent Recirculating System (MARS) offers a potential solution for liver support.
• Efficacy of MARS requires rigorous evaluation.

Purpose of the Study:

• To meta-analyze the efficacy of the Molecular Adsorbent Recirculating System (MARS).
• To assess MARS impact on bilirubin levels, hepatic encephalopathy, and mortality in liver failure.
• To evaluate MARS as a bridge therapy or temporary support.

Main Methods:

• Systematic search of MEDLINE, EMBASE, and Cochrane Registry.
• Inclusion of randomized and non-randomized controlled trials comparing MARS to standard medical therapy.
• Meta-analysis of outcomes including total bilirubin, hepatic encephalopathy grade, and mortality.

Main Results:

• MARS significantly decreased total bilirubin levels (net change -7.0 mg/dl).
• MARS demonstrated significant improvement in hepatic encephalopathy (OR 3.0).
• No significant beneficial effect of MARS on patient mortality was observed (OR 0.91).

Conclusions:

• MARS shows promise in improving key biochemical and neurological markers of liver failure.
• Current evidence does not support MARS for improving survival in liver failure patients.
• Further large-scale studies are needed to ascertain patient-centered outcomes with MARS therapy.